Endocyte: Market expander
07.06.2013 - US small molecule-drug conjugates specialist Endocyte has appointed Torsten Hoof as VP and General Manager of the company’s new European headquarters in Zug.
Hoof has extensive knowledge of product launches in the European market. The biochemist comes in from Bristol-Myers Squibb, where most recently he was VP for Global Commercialisation of the hema-tology and oncology franchise. Prior to joining BMS, he was Global Business Leader Influenza at Roche, where he led the worldwide launch of Tamiflu and several launches of HIV products in Germany.